Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

被引：0
作者：
Dhakchinamoorthi Krishna Kumar
Deepak Gopal Shewade
Marie-Anne Loriot
Philippe Beaune
Jayaraman Balachander
B. V. Sai Chandran
Chandrasekaran Adithan
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Pharmacology
[2] INSERM UMRS 775,University Paris Sorbonne Cité
[3] Assistance Publique des Hôpitaux de Paris,Department of Biochemistry, Georges Pompidou European Hospital
[4] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiology
[5] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiothoracic and Vascular Surgery
来源：
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词：
Warfarin; Genotype; Polymorphisms; Pharmacogenetic algorithm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [31] Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX polymorphisms on warfarin maintenance dose: Exploring a new algorithm in South Chinese patients accept mechanical heart valve replacement
    Li, Jin
    Chen, Tao
    Jie, Fangfang
    Xiang, Haiyan
    Huang, Li
    Jiang, Hongfa
    Lu, Fei
    Zhu, Shuqiang
    Wu, Lidong
    Tang, Yanhua
    MEDICINE, 2022, 101 (29) : E29626
  • [32] Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients
    Takuya Wakamiya
    Tatsunori Hokosaki
    Shin-ichi Tsujimoto
    Keisuke Kadota
    Yusuke Nakano
    Shigeo Watanabe
    Mari Iwamoto
    Masakatsu Yanagimachi
    Shuichi Ito
    Molecular Diagnosis & Therapy, 2016, 20 : 393 - 400
  • [33] Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population
    Mitchell, Cathrine
    Gregersen, Nerine
    Krause, Amanda
    PHARMACOGENOMICS, 2011, 12 (07) : 953 - 963
  • [34] Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy
    Shaw, Kaitlyn
    Amstutz, Ursula
    Kim, Richard B.
    Lesko, Lawrence J.
    Turgeon, Jacques
    Michaud, Veronique
    Hwang, Soomi
    Ito, Shinya
    Ross, Colin
    Carleton, Bruce C.
    THERAPEUTIC DRUG MONITORING, 2015, 37 (04) : 428 - 436
  • [35] The Frequency of CYP2C9, VKORC1, and CYP4F2 Polymorphisms in Russian Patients With High Thrombotic Risk
    Ivashchenko, Dmitriy
    Rusin, Ilya
    Sychev, Dmitriy
    Grachev, Audrey
    MEDICINA-LITHUANIA, 2013, 49 (12): : 517 - 521
  • [36] Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione
    Lacut, Karine
    Ayme-Dietrich, Estelle
    Gourhant, Lenaick
    Poulhazan, Elise
    Andro, Marion
    Becquemont, Laurent
    Mottier, Dominique
    Le Gal, Gregoire
    Verstuyft, Celine
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (03) : 428 - 436
  • [37] Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 -: Rationale and perspectives
    Yin, Tong
    Miyata, Toshiyuki
    THROMBOSIS RESEARCH, 2007, 120 (01) : 1 - 10
  • [38] A new algorithm to predict warfarin dose from polymorphisms of CYP4F2, CYP2C9 and VKORC1 and clinical variables: Derivation in Han Chinese patients with non valvular atrial fibrillation
    Wei, Meng
    Ye, Fei
    Xie, Dujiang
    Zhu, Yubing
    Zhu, Junrong
    Tao, Yifu
    Yu, Feng
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (06) : 1083 - 1091
  • [39] Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians
    Vargens, Daniela D.
    Damasceno, Albertino
    Petzl-Erler, Maria-Luiza
    Suarez-Kurtz, Guilherme
    PHARMACOGENOMICS, 2011, 12 (06) : 769 - 772
  • [40] Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction
    Kringen, Marianne K.
    Haug, Kari Bente Foss
    Grimholt, Runa M.
    Stormo, Camilla
    Narum, Sigrid
    Opdal, Mimi S.
    Fosen, Jan Toralf
    Piehler, Armin P.
    Johansen, Per W.
    Seljeflot, Ingebjorg
    Berg, Jens Petter
    Brors, Odd
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
12345